SCHEMBL96124

SCHEMBL96124

O=Cc1ccc2c(c1)c1ccccc1c(=O)n2Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.51
PTGER4 P35408 2/20 0.50
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
P2RX4 Q99571 1/20 0.49
MAPT P10636 4/20 0.47
CYP19A1 P11511 1/20 0.46
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPK1 P28482 1/20 0.46
LMNA P02545 1/20 0.45
PGR P06401 2/20 0.45
MAPK8 P45983 1/20 0.45
MAPK9 P45984 1/20 0.45
HPGD P15428 1/20 0.44
RORA P35398 1/20 0.44
RORC P51449 1/20 0.44
RORB Q92753 1/20 0.44
HSPD1 P10809 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL689732 0.88 PTGER4 (0.55) SRCPTGER4MEN1KMT2AP2RX4
SCHEMBL30676985 0.88 PTGER4 (0.55) SRCPTGER4MEN1KMT2AP2RX4
SCHEMBL689666 0.87 CYP19A1 (0.64) SRCPTGER4MEN1KMT2AP2RX4
SCHEMBL97196 0.86 PTGER4 (0.61) SRCPTGER4MEN1KMT2AMAPT
SCHEMBL97034 0.80 PIM1 (0.52) MEN1KMT2AHPGDPOLB
SCHEMBL97033 0.80 PIM1 (0.52) MEN1KMT2AHPGDPOLB
SCHEMBL8156486 0.80 PTGER4 (0.55) PTGER4MEN1KMT2AP2RX4CYP19A1
SCHEMBL14141638 0.78 RORA (0.70) PTGER4PGRRORARORCRORB
SCHEMBL28179541 0.77 MAPT (0.56) PTGER4MEN1KMT2AP2RX4MAPT
SCHEMBL96088 0.77 CFTR (0.50) SRCMEN1KMT2AP2RX4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
CN-101068810-B Carbostyril compound OTSUKA PHARMA CO LTD 2011-02-09 CN disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
CN-101068810-A Carbostyril compound OTSUKA PHARMA CO LTD (JP) 2007-11-07 CN disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 SRC 394/4885PTGER4 368/4885MEN1 3912/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 SRC 394/4885PTGER4 368/4885MEN1 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.